In my recent analysis, I explored the critical challenge faced by the pharmaceutical industry: ensuring the continuous availability of products. Stockouts of essential medications pose significant risks to public health and can lead to severe consequences, particularly for life-saving drugs.

I’ve felt a growing urge to take a different path—one where I build something of my own, take bigger risks, and pursue a vision without constraints. That itch has now outgrown my reasons to stay.